ITK and neoplasm: Besides BTK inhibition, it also affects other TEC family kinases, such as interleukin-2-inducible T-cell kinase (ITK), and therefore modifies cell adhesion within the tumor microenvironment as well as modulates chemotaxis and cell-to-cell signaling [42].